Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immediate early genes represent a class of genes that are rapidly and transiently induced in response to cellular stimuli, independent of protein synthesis. These genes are expressed within minutes of neuronal activity triggered by environmental stimuli and serve as critical mediators between external signals and long-term changes in cellular function. The Fos family, including FosB, c-Fos, Fra-1, and Fra-2, are proto-oncogenes that encode transcription factors. FosB is particularly notable for producing ΔFosB, a stable splice variant that lacks the C-terminal degron domain and persistently accumulates after chronic stimulation. This stability is enhanced by CAMKIIα phosphorylation at Ser37. c-Fos encodes a 380 amino acid, 62 kDa protein with a basic leucine zipper region for dimerization and DNA-binding, plus a C-terminal transactivation domain. It forms heterodimers with c-Jun to create the AP-1 complex, which binds specific DNA sequences to regulate target gene expression. Various stimuli including serum, growth factors, tumor promoters, cytokines, and UV radiation induce expression within 15 minutes. In the nervous system, immediate early genes play fundamental roles in myelination, vascularization, learning and memory, and synaptic plasticity. They are activated downstream of NMDA receptors and growth factors. The protein products can function as transcription factors (c-Fos, Egr family) or effector proteins (Arc) that directly influence cellular function. The involvement in both normal physiology and disease pathology, combined with context-dependent effects, makes immediate early gene expression a complex biological process rather than a straightforward therapeutic target.
Rather than being drug targets themselves, immediate early genes function through several mechanisms: FosB protein dimerizes with Jun family proteins to form AP-1 (Activator Protein-1) transcription factor complex. AP-1 binds DNA at specific promoter and enhancer regions to regulate target gene expression. c-Fos expression is stimulated by cAMP and Ca²⁺ through CREB/CRE complex activation. ΔFosB regulates genes including GluR2, CAMKIIα, and influences G9a repressive histone methylation. Posttranslational modifications by kinases (MAPK, CDC2, PKA, PKC) regulate protein stability and DNA-binding activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immediate early gene expression, including FosB (IEG).